Position in CGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,814,309
-$248,440 QoQ
Shares Held
3,184,257
-4.0% QoQ
Ownership
3.36%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#1
of 82 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Derivatives in CGEN
reported options exposure · as of Dec 31, 2021CallValue
$245,100
CallShares
57,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SILVERARC CAPITAL MANAGEMENT, LLC holds $802,586,993 across 53 Biotechnology names. CGEN ranks #33 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
206,234 | $55,006,732 | |
| 2 | CELC |
Celcuity Inc.
|
500,996 | $52,414,201 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,280,707 | $49,563,360 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
1,301,979 | $47,912,827 | |
| 5 | IMNM |
Immunome Inc.
|
2,017,009 | $42,740,420 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
390,000 | $38,017,200 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
311,461 | $34,581,514 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
352,802 | $33,576,166 |
All Filings in CGEN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,814,309 | 3,184,257 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,062,749 | 3,315,845 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,324,101 | 3,479,805 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,867,412 | 3,311,165 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,400,304 | 3,033,879 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,227,327 | 2,895,430 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,485,296 | 1,624,377 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,717,014 | 1,501,113 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,521,869 | 1,501,113 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,580,000 | 1,000,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,861,200 | 940,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $325,674 | 350,188 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $376,414 | 330,188 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $231,131 | 330,188 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $480,558 | 667,443 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $192,677 | 104,150 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $864,879 | 268,596 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $699,188 | 162,602 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $245,100 | 57,000 | Call | Sole | 2022-02-14 | |
| 2021-09-30 | $1,215,086 | 203,532 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $1,480,560 | 248,000 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $1,731,455 | 209,113 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $644,250 | 75,000 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $1,823,160 | 150,550 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||